SG11201506494XA - Methods for purifying antibodies - Google Patents
Methods for purifying antibodiesInfo
- Publication number
- SG11201506494XA SG11201506494XA SG11201506494XA SG11201506494XA SG11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- purifying antibodies
- antibodies
- purifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361787309P | 2013-03-15 | 2013-03-15 | |
PCT/IB2014/059755 WO2014141150A1 (en) | 2013-03-15 | 2014-03-13 | Methods for purifying antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201506494XA true SG11201506494XA (en) | 2015-09-29 |
Family
ID=50391244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201506494XA SG11201506494XA (en) | 2013-03-15 | 2014-03-13 | Methods for purifying antibodies |
Country Status (15)
Country | Link |
---|---|
US (2) | US10676503B2 (en) |
EP (3) | EP3680000B1 (en) |
JP (2) | JP6599773B2 (en) |
KR (1) | KR102114021B1 (en) |
CN (1) | CN105188872B (en) |
AU (1) | AU2014229280B2 (en) |
BR (1) | BR112015022321A2 (en) |
CA (1) | CA2902287A1 (en) |
DK (2) | DK3680000T3 (en) |
ES (1) | ES2765206T3 (en) |
IL (1) | IL240753B (en) |
RU (1) | RU2651483C2 (en) |
SG (1) | SG11201506494XA (en) |
TW (1) | TWI625335B (en) |
WO (1) | WO2014141150A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2765206T3 (en) * | 2013-03-15 | 2020-06-08 | Glaxosmithkline Ip No 2 Ltd | Antibody purification procedures |
JP2016519145A (en) | 2013-05-15 | 2016-06-30 | メディミューン リミテッド | Purification of recombinantly produced polypeptides |
EP3137186B1 (en) | 2014-04-30 | 2021-01-27 | Novo Nordisk A/S | Methods for the purification of proteins using caprylic acid |
WO2016121701A1 (en) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | AFFINITY SEPARATION MATRIX FOR PURIFYING PROTEIN CONTAINING IMMUNOGLOBULIN κ CHAIN VARIABLE REGION |
WO2016121703A1 (en) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | MUTANT IMMUNOGLOBULIN κ CHAIN VARIABLE REGION-BINDING PEPTIDE |
WO2017195638A1 (en) | 2016-05-09 | 2017-11-16 | 株式会社カネカ | Method for refining antibody or antibody fragment containing κ-chain variable region |
EP4389757A2 (en) * | 2016-09-07 | 2024-06-26 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
CN106939045B (en) * | 2017-05-01 | 2020-03-31 | 深圳市国创纳米抗体技术有限公司 | Method for clarifying monoclonal antibody cell culture solution |
CN108085358A (en) * | 2018-02-08 | 2018-05-29 | 保定冀中药业有限公司 | A kind of preparation method of canine parvovirus monoclonal antibody IgG2b-Fab segments |
TW202003555A (en) * | 2018-03-07 | 2020-01-16 | 英商葛蘭素史克智慧財產發展有限公司 | Methods for purifying recombinant polypeptides |
TW202000891A (en) | 2018-03-07 | 2020-01-01 | 英商葛蘭素史克智慧財產發展有限公司 | Methods for purifying antibodies |
CN114133446A (en) * | 2021-12-31 | 2022-03-04 | 方坦思(上海)生物医药有限公司 | Method for purifying monoclonal antibody |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57106673A (en) | 1980-12-24 | 1982-07-02 | Chugai Pharmaceut Co Ltd | Dibenzo(b,f)(1,4)oxazepin derivative |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US6955917B2 (en) | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
ATE455468T1 (en) * | 2001-06-01 | 2010-02-15 | Upfront Chromatography As | FRACTIONATION OF MIXTURES CONTAINING PROTEIN |
EP2277914A3 (en) | 2001-08-10 | 2012-08-08 | Aberdeen University | Antigen binding domains from fish |
KR20050026396A (en) | 2002-05-31 | 2005-03-15 | 인디언 카운실 오브 애그리컬쳐럴 리서치 | Rapid detection of bt-cry toxins |
ES2407380T5 (en) | 2004-02-27 | 2017-07-07 | Octapharma Ag | Procedure to provide a purified antibody preparation, with no risk for viruses |
EP1786827A4 (en) * | 2004-05-14 | 2008-10-29 | Kirin Holdings Kk | Methods for immunoglobulin purification |
WO2007109163A2 (en) * | 2006-03-16 | 2007-09-27 | Amgen Inc | Wash buffer and method of using |
US20080167450A1 (en) * | 2007-01-05 | 2008-07-10 | Hai Pan | Methods of purifying proteins |
DK2691411T3 (en) * | 2011-03-29 | 2020-05-11 | Glaxosmithkline Llc | PROTEIN PURIFICATION BUFFER SYSTEM |
ES2765206T3 (en) * | 2013-03-15 | 2020-06-08 | Glaxosmithkline Ip No 2 Ltd | Antibody purification procedures |
JP2016519145A (en) | 2013-05-15 | 2016-06-30 | メディミューン リミテッド | Purification of recombinantly produced polypeptides |
-
2014
- 2014-03-13 ES ES14713926T patent/ES2765206T3/en active Active
- 2014-03-13 KR KR1020157029042A patent/KR102114021B1/en active IP Right Grant
- 2014-03-13 BR BR112015022321A patent/BR112015022321A2/en not_active Application Discontinuation
- 2014-03-13 WO PCT/IB2014/059755 patent/WO2014141150A1/en active Application Filing
- 2014-03-13 DK DK19198005.1T patent/DK3680000T3/en active
- 2014-03-13 TW TW103108898A patent/TWI625335B/en active
- 2014-03-13 CA CA2902287A patent/CA2902287A1/en not_active Abandoned
- 2014-03-13 CN CN201480016016.XA patent/CN105188872B/en active Active
- 2014-03-13 RU RU2015136860A patent/RU2651483C2/en active
- 2014-03-13 JP JP2015562513A patent/JP6599773B2/en active Active
- 2014-03-13 DK DK14713926.5T patent/DK2969098T3/en active
- 2014-03-13 EP EP19198005.1A patent/EP3680000B1/en active Active
- 2014-03-13 SG SG11201506494XA patent/SG11201506494XA/en unknown
- 2014-03-13 EP EP24155364.3A patent/EP4371996A2/en active Pending
- 2014-03-13 AU AU2014229280A patent/AU2014229280B2/en not_active Ceased
- 2014-03-13 US US14/775,868 patent/US10676503B2/en active Active
- 2014-03-13 EP EP14713926.5A patent/EP2969098B1/en active Active
-
2015
- 2015-08-23 IL IL240753A patent/IL240753B/en active IP Right Grant
-
2019
- 2019-10-03 JP JP2019182562A patent/JP7002511B2/en active Active
-
2020
- 2020-05-13 US US15/931,062 patent/US20200277330A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
TW201522365A (en) | 2015-06-16 |
AU2014229280B2 (en) | 2017-01-05 |
JP2020019795A (en) | 2020-02-06 |
KR20150131235A (en) | 2015-11-24 |
KR102114021B1 (en) | 2020-05-22 |
EP2969098A1 (en) | 2016-01-20 |
ES2765206T3 (en) | 2020-06-08 |
AU2014229280A1 (en) | 2015-10-01 |
EP4371996A2 (en) | 2024-05-22 |
TWI625335B (en) | 2018-06-01 |
US20200277330A1 (en) | 2020-09-03 |
CA2902287A1 (en) | 2014-09-18 |
WO2014141150A1 (en) | 2014-09-18 |
BR112015022321A2 (en) | 2017-07-18 |
CN105188872A (en) | 2015-12-23 |
EP3680000B1 (en) | 2024-03-13 |
US20160024146A1 (en) | 2016-01-28 |
US10676503B2 (en) | 2020-06-09 |
EP3680000A1 (en) | 2020-07-15 |
CN105188872B (en) | 2019-01-15 |
IL240753B (en) | 2021-01-31 |
DK2969098T3 (en) | 2020-01-27 |
JP2016519052A (en) | 2016-06-30 |
RU2651483C2 (en) | 2018-04-19 |
DK3680000T3 (en) | 2024-04-02 |
IL240753A0 (en) | 2015-10-29 |
RU2015136860A (en) | 2017-04-28 |
JP7002511B2 (en) | 2022-02-21 |
JP6599773B2 (en) | 2019-10-30 |
EP2969098B1 (en) | 2019-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL269528A (en) | Anti-fcrh5 antibodies | |
HK1217344A1 (en) | Purification process for monoclonal antibodies | |
PT3004163T (en) | Method for purifying antibody | |
GB201322583D0 (en) | Antibodies | |
IL240753B (en) | Methods for purifying antibodies | |
HK1220142A1 (en) | Antibodies | |
GB201308658D0 (en) | Antibodies | |
EP2987801A4 (en) | Method for purifying antibody protein | |
GB201315486D0 (en) | Antibodies | |
IL245488A0 (en) | Anti-ccl17 antibodies | |
GB201318283D0 (en) | Antibodies |